{"id":140534,"date":"2023-02-08T05:08:59","date_gmt":"2023-02-08T10:08:59","guid":{"rendered":"https:\/\/44.250.171.167\/?p=140534"},"modified":"2023-02-08T05:09:01","modified_gmt":"2023-02-08T10:09:01","slug":"granules-india-limited-q3-fy23-pat-jumped-up-to-124-crore","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/granules-india-limited-q3-fy23-pat-jumped-up-to-124-crore\/","title":{"rendered":"Granules India Limited Q3 FY23; PAT Jumped Up To 124 Crore"},"content":{"rendered":"

Granules India Limited<\/a> (NSE: GRANULES<\/a>) reported Revenue from Operations for Q3 FY23 of \u20b91,146.12 Crore up from \u20b9996.76 Crore year on year, a growth of 15%. Consolidated Net Profit of \u20b9124.32 Crore, up 23% from \u20b9100.88 Crore in the same quarter of the previous year. The Earnings per Share is \u20b95.10 for this quarter.<\/p>\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Granules India Limited (NSE: GRANULES) reported Revenue from Operations for Q3 FY23 of \u20b91,146.12 Crore up from \u20b9996.76 Crore year on year, a growth of 15%. Consolidated Net Profit of \u20b9124.32 Crore, up 23% from \u20b9100.88 Crore in the same quarter of the previous year. The Earnings per Share is \u20b95.10 for this quarter.<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[1115],"class_list":["post-140534","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":146247,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q4-fy23\/","url_meta":{"origin":140534,"position":0},"title":"Earnings Summary Of Granules India Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 16, 2023","format":false,"excerpt":"Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). With a strong focus on quality, innovation, and customer satisfaction, Granules India has established itself as a\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":146250,"url":"https:\/\/alphastreet.com\/india\/granules-india-limited-q4-fy23-net-profit-increased-by-8\/","url_meta":{"origin":140534,"position":1},"title":"Granules India Limited Q4 FY23; Net Profit Increased By 8%","author":"Hardik Bhandare","date":"May 16, 2023","format":false,"excerpt":"Granules India Limited reported Total Income for Q4 FY23 of \u20b91,198.87 Crore up from \u20b91,033.93 Crore year on year, a growth of 16%. Consolidated Net Profit of \u20b9119.60 Crore, up 7.7% from \u20b9111 Crore in the same quarter of the previous year. The Earnings per Share is \u20b94.93, from \u20b94.46\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":141857,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q3-fy23\/","url_meta":{"origin":140534,"position":2},"title":"Earnings Summary Of Granules India Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 15, 2023","format":false,"excerpt":"Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has grown to become a leading producer of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulations, and other healthcare products. Revenue from Operations was \u20b91,146 Cr, up 15% year on year,\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":177861,"url":"https:\/\/alphastreet.com\/india\/granules-india-q3-fy26-earnings-results\/","url_meta":{"origin":140534,"position":3},"title":"Granules India Q3 FY26 Earnings Results","author":"Divyansh_Kasana","date":"January 27, 2026","format":false,"excerpt":"Executive Summary Granules India Ltd reported Q3FY26 revenues of \u20b91,388 crore, up 21.97% YoY, with consolidated net profit rising 27.12% to \u20b9150 crore. Total expenses increased 19.37% YoY to \u20b91,183 crore, reflecting efficient cost management amid strong revenue growth. Revenue & Growth Revenues grew to \u20b91,388.00 crore in Q3FY26 from\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/G-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172455,"url":"https:\/\/alphastreet.com\/india\/granules-india-q2-fy26-earnings-results\/","url_meta":{"origin":140534,"position":4},"title":"Granules India Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 18, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries, specializing in Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, posted impressive financial results for Q2FY26. Financial Highlights: Revenues increased 34.13% year-on-year to \u20b91,297 crore from \u20b9967 crore. Total expenses rose 33.02% to \u20b91,120 crore from \u20b9842 crore. Consolidated net profit\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142087,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-gujarat-fluorochemicals-limited-for-q3-fy23\/","url_meta":{"origin":140534,"position":5},"title":"Earnings Summary Of Gujarat Fluorochemicals Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 16, 2023","format":false,"excerpt":"Gujarat Fluorochemicals Limited (NSE: FLUOROCHEM) is a leading chemical manufacturing company with a presence in India and international markets. The company specializes in the production of fluorochemicals, which are used in a range of applications, including refrigeration, air conditioning, and polymer processing. In terms of earnings, Revenue from Operations for\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/140534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=140534"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/140534\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=140534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=140534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=140534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}